Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT)
NCT00032890Phase 3Completed
- Sponsor
- United States Department of Veterans Affairs
- Start
- Apr 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of glucosamine sulphate and chondroitin sulfate in osteoarthritis (OA) (5 arms), sponsored by United States Department of Veterans Affairs. Primary endpoints: Treatment Responders (20% reduction in WOMAC pain subscale) at 24 weeks and Change in Joint Space Width at 2 years. Started Apr 2000; status: completed.
02
Drugs
glucosamine sulphatechondroitin sulfate
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00032890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00032890.